These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12362414)

  • 1. Phenotypic variability among first-degree relatives with carnitine palmitoyltransferase II deficiency.
    Vladutiu GD; Bennett MJ; Fisher NM; Smail D; Boriack R; Leddy J; Pendergast DR
    Muscle Nerve; 2002 Oct; 26(4):492-8. PubMed ID: 12362414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene.
    Vladutiu GD; Bennett MJ; Smail D; Wong LJ; Taggart RT; Lindsley HB
    Mol Genet Metab; 2000 Jun; 70(2):134-41. PubMed ID: 10873395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutations associated with carnitine palmitoyltransferase II deficiency.
    Taggart RT; Smail D; Apolito C; Vladutiu GD
    Hum Mutat; 1999; 13(3):210-20. PubMed ID: 10090476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations.
    Ørngreen MC; Dunø M; Ejstrup R; Christensen E; Schwartz M; Sacchetti M; Vissing J
    Ann Neurol; 2005 Jan; 57(1):60-6. PubMed ID: 15622536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel mutations in Spanish patients with muscle carnitine palmitoyltransferase II deficiency.
    Martín MA; Rubio JC; del Hoyo P; García A; Bustos F; Campos Y; Cabello A; Culebras JM; Arenas J
    Hum Mutat; 2000 Jun; 15(6):579-80. PubMed ID: 10862092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of four novel mutations in patients with carnitine palmitoyltransferase II (CPT II) deficiency.
    Yang BZ; Ding JH; Dewese T; Roe D; He G; Wilkinson J; Day DW; Demaugre F; Rabier D; Brivet M; Roe C
    Mol Genet Metab; 1998 Aug; 64(4):229-36. PubMed ID: 9758712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnitine palmitoyltransferase deficiencies.
    Bonnefont JP; Demaugre F; Prip-Buus C; Saudubray JM; Brivet M; Abadi N; Thuillier L
    Mol Genet Metab; 1999 Dec; 68(4):424-40. PubMed ID: 10607472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects.
    Deschauer M; Wieser T; Zierz S
    Arch Neurol; 2005 Jan; 62(1):37-41. PubMed ID: 15642848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carnitine palmitoyltransferase II (CPT II) deficiency: genotype-phenotype analysis of 50 patients.
    Joshi PR; Deschauer M; Zierz S
    J Neurol Sci; 2014 Mar; 338(1-2):107-11. PubMed ID: 24398345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutation identified in carnitine palmitoyltransferase II deficiency.
    Yang BZ; Ding JH; Roe D; Dewese T; Day DW; Roe CR
    Mol Genet Metab; 1998 Feb; 63(2):110-5. PubMed ID: 9562964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects.
    Bonnefont JP; Djouadi F; Prip-Buus C; Gobin S; Munnich A; Bastin J
    Mol Aspects Med; 2004; 25(5-6):495-520. PubMed ID: 15363638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent myoglobinuria due to carnitine palmitoyltransferase II deficiency: clinical, biochemical, and genetic features of adult-onset cases.
    Kilfoyle D; Hutchinson D; Potter H; George P
    N Z Med J; 2005 Feb; 118(1210):U1320. PubMed ID: 15776096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the infant-type R631C mutation in patients with the benign muscular form of CPT2 deficiency.
    Musumeci O; Aguennouz M; Comi GP; Rodolico C; Autunno M; Bordoni A; Baratta S; Taroni F; Vita G; Toscano A
    Neuromuscul Disord; 2007 Dec; 17(11-12):960-3. PubMed ID: 17651973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel nonsense mutation (515del4) in muscle carnitine palmitoyltransferase II deficiency.
    Deschauer M; Wieser T; Schröder R; Zierz S
    Mol Genet Metab; 2002 Feb; 75(2):181-5. PubMed ID: 11855939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular analysis of a patient with carnitine palmitoyltransferase II deficiency].
    Akanuma J; Wataya K; Matubara Y; Yamamoto T; Kira J; Narisawa K
    Rinsho Shinkeigaku; 1997 Jun; 37(6):532-5. PubMed ID: 9366186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of 16 new disease-causing mutations in the CPT2 gene resulting in carnitine palmitoyltransferase II deficiency.
    Isackson PJ; Bennett MJ; Vladutiu GD
    Mol Genet Metab; 2006 Dec; 89(4):323-31. PubMed ID: 16996287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rhabdomyolysis in carnitine palmitoyltransferase II deficiency: developments in pathophysiology, diagnosis and therapy].
    Imoberdorf R; Krähenbühl S; Krapf R
    Schweiz Med Wochenschr; 1998 Jun; 128(25):1024-9. PubMed ID: 9691338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel splice site mutation in neonatal carnitine palmitoyl transferase II deficiency.
    Smeets RJ; Smeitink JA; Semmekrot BA; Scholte HR; Wanders RJ; van den Heuvel LP
    J Hum Genet; 2003; 48(1):8-13. PubMed ID: 12560872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency.
    Olpin SE; Afifi A; Clark S; Manning NJ; Bonham JR; Dalton A; Leonard JV; Land JM; Andresen BS; Morris AA; Muntoni F; Turnbull D; Pourfarzam M; Rahman S; Pollitt RJ
    J Inherit Metab Dis; 2003; 26(6):543-57. PubMed ID: 14605500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations in CPT 1A define molecular heterogeneity of hepatic carnitine palmitoyltransferase I deficiency.
    Bennett MJ; Boriack RL; Narayan S; Rutledge SL; Raff ML
    Mol Genet Metab; 2004 May; 82(1):59-63. PubMed ID: 15110323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.